Back to Search Start Over

Hyperbaric Oxygen Therapy Combined with Immunosuppression for Acute Macular Neuroretinopathy in Systemic Lupus Erythematosus.

Authors :
Shroff, Daraius
Kothari, Abhishek
Gupta, Priyanka
Sahni, Tarun Kumar
Narain, Shishir
Source :
Ocular Immunology & Inflammation. Feb2023, Vol. 31 Issue 2, p355-361. 7p.
Publication Year :
2023

Abstract

To describe the use of hyperbaric oxygen therapy (HBOT) in conjunction with immunosuppression for acute macular neuroretinopathy (AMN) in systemic lupus erythematosus (SLE). Two known cases of SLE presented to us with blurred vision and paracentral scotomas due to AMN. Both cases reported worsening of their conditions despite the initiation of high-dose steroid therapy. HBOT was added on as a treatment modality to address vaso-occlusive ischemic injury. Both patients underwent a total of twelve cycles of HBOT. Functional and anatomical improvements were noted immediately after the initiation of therapy and were maintained over more than one year of follow-up. No significant retinal thinning was noted on optical coherence tomography on disease resolution, as has been noted previously. Visual field scotoma showed a complete resolution. Our cases suggest that HBOT may have a role in aiding functional and anatomical recovery in AMN associated with SLE. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09273948
Volume :
31
Issue :
2
Database :
Academic Search Index
Journal :
Ocular Immunology & Inflammation
Publication Type :
Academic Journal
Accession number :
161969901
Full Text :
https://doi.org/10.1080/09273948.2022.2029497